Hana Financial Group's Gangnam headquarters (left) and T. K. Corporation Tower. /Courtesy of Hana Asset Trust

Hana Office REIT, the first public offering listed REIT of Hana Financial Group, will begin book building for institutional investors this week (Mar. 23–27). Inventera, a specialist in magnetic resonance imaging (MRI) contrast agent NANO pharmaceuticals, will take retail subscriptions.

According to the financial investment industry on the 22nd, Hana Office REIT will conduct book building for institutional investors over two trading days on the 23rd–24th. After confirming the offer price, retail investor subscriptions will run from the 31st to Apr. 1. The listing is scheduled for Apr. 17.

A REIT is a real estate indirect investment vehicle company that pools investment funds to generate revenue through real estate assets. The offer price is set at 5,000 won per share, and the offering size is set at 126 billion won. 82 billion won is allocated to institutional investors, and 44 billion won to retail investors.

Hana Office REIT's assets are two properties: Hana Financial Group's Gangnam headquarters near Gangnam Station and Taekwang Tower. As a principle, more than 80% of total assets will be offices, and in particular, more than 50% will be assets in the Gangnam area, which has a low vacancy rate.

Inventera, a specialist in NANO pharmaceutical development, will take retail investor subscriptions from the 23rd to the 24th. From the 11th to the 17th over five trading days, it conducted book building for institutional investors and set the offer price at 16,600 won, the top end of the desired price band.

The book building for Chaevi, an electric vehicle charging infrastructure operator (CPO) that set its post-listing valuation at up to 729.7 billion won, has been pushed to next month. It had planned to conduct book building for institutional investors from the 23rd to the 27th, but it was postponed due to an amended securities registration statement.

Meanwhile, this week, Hanpass, an integrated lifestyle and financial platform for foreigners, and MEZOO, a Digital Healthcare corporation touting remote patient monitoring technology, will debut on the KOSDAQ market side by side. Specifically, Hanpass will list on the 25th, and MEZOO on the 26th, on the KOSDAQ market.

※ This article has been translated by AI. Share your feedback here.